Browsing: lands

Co-founder Hanadie Yousef to step down as CEO as company gears up for more clinical trials of drugs designed to…

Company aims to extend human healthspan via a combination of preventive RNAi therapeutics and AI-powered risk prediction. Preventive health biotech…

Liom boasts miniaturization breakthrough in spectroscopy-powered continuous glucose monitoring technology.   Swiss healthtech startup Liom has secured a $16.5 million…

Startup targets ‘brainspan’ with EEG-powered headphones designed to make monitoring cognitive health as normal as heart rate. Consumer neurotech company…

Bets on automation underscore investor confidence in industrializing cell therapies as patient demand continues to outpace supply. Cellular Origins, a…

Initial focus on epilepsy could drive progress in aging and healthspan therapeutics targeting the mTOR pathway. US biotech Aeovian Pharmaceuticals…

Subsense secures additional $10m following progress towards nanoparticle-based approach to neural interface control. Neurotech startup Subsense has expanded its total…

With programs targeting Alzheimer’s and Parkinson’s, company targets several major drivers of neurodegenerative disease. US biotech SciNeuro Pharmaceuticals has secured…

Approach aims to identify multiple disease-driven molecular changes, long before cognitive decline becomes apparent. Brain health diagnostics company Circular Genomics…

MindImmune targets clinical trials of drug that blocks the harmful recruitment of peripheral immune cells into the brain. US biotech…